Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

EARNINGS UPDATES: Brandshield grows revenue; Xtract loss widens

30th Jun 2022 20:30

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Brandshield Systems PLC - London-based cybersecurity solutions provider - Revenue in 2021 jumps to GBP4.1 million from GBP2.6 million year-on-year, as pretax loss widens to GBP6.3 million from GBP3.3 million. Annual recurring revenue rises 59% to GBP5.2 million from GBP3.2 million in 2020. Adds 10 new customers between January and May of 2022, and May ARR stands at GBP6.3 million, a 67% increase year-on-year. Trades in line with expectations for the current year. "The company delivered a strong performance across 2021, and, pleasingly, that momentum has continued into 2022, with BrandShield having already secured a number of new mandates with companies across a wide array of sectors. Revenue growth and new business development continues to be a focused strategy for management alongside expanding the group market share and profile," says Chief Executive Officer Yoav Keren.

----------

Xtract Resources PLC - mining company focused on Africa and Australia - Revenue from gold sales in 2021 drops to GBP692,000 compared to GBP1.7 million in 2020, as pretax loss widens GBP3.1 million from GBP807,000. "Our mission to work small scale mining operations and conduct major exploration has advanced according to plan...The company is examining a number of exciting opportunities in the small copper and gold sector and look forward to reporting progress during the 3rd quarter," says Chair Colin Bird.

----------

Apollon Formularies PLC - London-based medical cannabis pharmaceutical firm - Revenue in 2021 comes in at GBP191,671 compared to no revenue in 2020, as pretax loss widens to GBP2.5 million from GBP496,939 the year before. "As we look ahead through the second half of 2022 into 2023 and beyond, there are several key developments that the company intends to make. A major priority for Apollon is exporting its first line of products to South Africa for continued academic research with its academic affiliates in the region, and for patients to access through prescription under S21 guidelines in South Africa. Apollon will continue engagement with the South African Health Products Regulatory Authority to start the licensed medication process in the region," the firm says.

----------

Sure Ventures PLC - London-based investment and venture capital company - In the six months ended March 31, revenue rises to GBP4.1 million from GBP1.5 million in the 16 months to September 30, 2021, as pretax loss narrows to GBP815,472 from GBP1.0 million. In the six months ended January 31, 2021 revenue was GBP11,803 and pretax loss was GBP132,944. "We are pleased to report solid revenue growth as a group for our half-year, reflecting a few months of ownership of our recent acquisitions. The headwinds of the market have provided some challenges with regards to labour supply, labour costs, ingredients and sourcing. The business is moving towards an even keel and in these numbers we have exceptional legal and infrastructure investment costs to support our building of a combined platform and hub for future growth," the company says. Expects the fundraising environment to remain challenging and for headwinds from supply chain troubles and inflation to remain for time being, but says this is offset by "incredible opportunities" for acquisitions.

----------

RentGuarantor Holdings PLC - London-based provider of rent guarantee services - Revenue in 2021 is GBP241,033, doubled year-on-year from GBP121,411, as pretax loss widens to GBP1.5 million from GBP468,970. Remains in positive cash position, bolstered in 2022 by proceeds from convertible loans. "The economic and geo-political environments are bringing great uncertainty for many, and we are conscious of the challenges this brings for our customers and the market we operate in. This also brings opportunities as we take a cautious but considered approach to the group's long-term strategy. We believe that the long-term opportunity remains significant," says Executive Chair Graham Duncan.

----------

Premier African Minerals Ltd - British Virgin Islands-based minerals and metals project developer - Records no revenue in 2021, and swings to pretax profit of USD2.3 million from loss of GBP1.3 million in 2020. Net assets at December-end rise to USD14.2 million from USD8.5 million. "Premier concluded a joint venture agreement with Li3 Resources Inc to earn in up to 50% of the ownership of the claims previously acquired in the Mutare greenstone belt. Exploration activities have commenced and we look forward to results of those efforts in the near future," says CEO George Roach.

----------

Pharma C Investments PLC - New Jersey-based early-stage investor in the medical cannabis industry - Pretax loss in 2021 widens to GBP517,000 from GBP92,00 year-on-year. Reports no revenue for either period. "The directors strongly believe that the market sector which the company is focused upon investing in is going through a very exciting, transitional period. At the same time, they also believe that the company is well placed to deploy funds in line with the company's stated aims and that the investments in Product Earth and Celadon demonstrate the exciting opportunities available for investment," says Chair Sharon Segal.

----------

By Elizabeth Winter; [email protected]

Copyright 2022 Alliance News Limited. All Rights Reserved.

FTSE 100 Latest
Value8,100.42
Change60.04